Skip to main content
# Title Department Research Member Research Year
31 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2023
32 Visceral and Subcutaneous Fat, Muscle Mass, and Liver Volume as Non-invasive Predictors of the Progress of Non-alcoholic Fatty Liver Disease Department of Radiology Dr. Omar Mustafa Mahmoud Mohamed 2023
33 18F-FDG gallbladder uptake: observation from a total-body PET/CT scanner Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2023
34 Value of FoxO3a Gene Expression in Pediatric Acute Lymphoblastic Leukemia Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2023
35 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Ahmed Refaat Abdel Zaher Mubarak 2023
36 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Dr. Badawy, Mohammed Ahmed Mohammed 2023
37 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Amany Mohammed Abdel Moatamed 2023
38 Could Local Surgery Improve Survival in Stage IV Breast Cancer? Department of Surgical Oncology Prof. Hesham Mahmoud Mohamed Mahmoud 2023
39 Efficacy of pectoralis plane block versus wound instillation using ketamine with bupivacaine on postoperative analgesia following modified radical mastectomy, a randomized study Department of Anesthesia, Intensive care and Pain management Dr. Ahmad Mohammad Abd El-Rahman 2023
40 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Department of Medical Oncology Dr. Amen Hamdy Zaki Ali 2023